CASTLE ROCK, Colo.,
Oct. 4, 2017 /PRNewswire/
-- Bioptix Inc. (Nasdaq: BIOP) today announced it is changing
its name to Riot Blockchain, Inc., and has reserved and plans to
change its Nasdaq ticker symbol to RIOT, in line with a shift
in direction of the company. The name and symbol change are subject
to Nasdaq approval. Moving forward, Riot Blockchain's focus will be
as a strategic investor and operator in the blockchain ecosystem
with a particular focus on the Bitcoin and Ethereum
blockchains.
As part of this focus, the company announces it has made a
strategic investment in Coinsquare Ltd., one of Canada's leading exchanges for trading digital
currencies. This investment into a blockchain-focused company is
indicative of similar opportunities Riot Blockchain plans to
pursue, including possible acquisitions of businesses serving the
blockchain ecosystem.
"At Riot Blockchain, our team has the insight and network to
effectively grow and develop blockchain assets," said Michael Beeghley, Chief Executive Officer of
Riot Blockchain. "With new applications being developed for
blockchain every day, this is a rapidly growing and evolving
market. We are excited to have partnered with and led an investment
in Coinsquare, a company we believe is well positioned to
capitalize on the opportunity in this sector."
Blockchain protocols offer a secure way to store and relay
information without the need for middlemen. It uses a decentralized
and encrypted ledger that offers a secure, efficient, verifiable,
and permanent way of storing records and other information.
Blockchain protocols are the backbone of numerous digital
cryptocurrencies including Bitcoin, Ethereum and Litecoin. They
have a wide range of potential applications including use in
processing transactions, managing medical records, recording votes
and proof of ownership across a far-reaching spectrum of
applications.
About Riot Blockchain
Riot Blockchain Inc. (formerly Bioptix, Inc.) leverages its
expertise and network to build and support blockchain technology
companies. It is establishing an Advisory Board with technical
experience intending to become a leading authority and supporter of
blockchain and provides investment exposure to the rapidly growing
blockchain ecosystem. For more information, visit
http://www.riotblockchain.com/.
The company continues to maintain its existing Bioptix business
line and its royalty license stemming from an Exclusive License
Agreement with Ceva Santé Animale S.A. ("Licensee"), providing an
exclusive worldwide royalty-bearing license, until December 31, 2028, to develop, seek regulatory
approval for and offer to sell, market, distribute, import and
export luteinizing hormone ("LH") and/or follicle-stimulating
hormone ("FSH") products for cattle, equine and swine for the
assistance and facilitation of reproduction.
Safe Harbor
The information provided in this press release may include
forward-looking statements relating to future events or the future
financial performance of the Company. Because such statements are
subject to risks and uncertainties, actual results may differ
materially from those expressed or implied by such forward-looking
statements. Words such as "anticipates," "plans," "expects,"
"intends," "will," "potential," "hope" and similar expressions are
intended to identify forward-looking statements. These
forward-looking statements are based upon current expectations of
the Company and involve assumptions that may never materialize or
may prove to be incorrect. Actual results and the timing of events
could differ materially from those anticipated in such
forward-looking statements as a result of various risks and
uncertainties. Detailed information regarding factors that may
cause actual results to differ materially from the results
expressed or implied by statements in this press release relating
to the Company may be found in the Company's periodic filings with
the Securities and Exchange Commission, including the factors
described in the sections entitled "Risk Factors", copies of which
may be obtained from the SEC's website at www.sec.gov. The parties
do not undertake any obligation to update forward-looking
statements contained in this press release.
Media Contacts
Karen
Chase or Travis Kruse
Russo Partners, LLC
(646) 942-5627
(212) 845-4272
karen.chase@russopartnersllc.com
travis.kruse@russopartnersllc.com
View original
content:http://www.prnewswire.com/news-releases/bioptix-changing-name-to-riot-blockchain-as-company-shifts-focus-to-strategic-investor-and-operator-in-blockchain-technologies-300530737.html
SOURCE Bioptix, Inc.